Oncotelic Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Oncotelic Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Oncotelic Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$3.28M, a 22760% decline year-over-year.
  • Oncotelic Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$3.62M, a 67.4% increase year-over-year.
  • Oncotelic Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$6.65M, a 31.6% increase from 2022.
  • Oncotelic Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$9.72M, a 6.53% decline from 2021.
  • Oncotelic Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$9.13M, a 20.3% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$3.62M -$3.28M -$3.3M -22760% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-19
Q2 2024 -$326K -$96.6K +$6.23M +98.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$6.55M -$167K +$96.9K +36.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$6.65M -$76.5K +$4.45M +98.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-12
Q3 2023 -$11.1M $14.5K +$610K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-19
Q2 2023 -$11.7M -$6.32M -$6.07M -2366% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$5.64M -$264K +$4.08M +93.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$9.72M -$4.53M -$3.01M -199% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-12
Q3 2022 -$6.71M -$595K +$1.21M +67.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$7.92M -$256K +$3.51M +93.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-18
Q1 2022 -$11.4M -$4.34M -$2.31M -113% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q4 2021 -$9.13M -$1.51M +$1.82M +54.6% Oct 1, 2021 Dec 31, 2021 10-K/A 2023-04-20
Q3 2021 -$10.9M -$1.81M -$193K -11.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-18
Q2 2021 -$10.8M -$3.76M -$3.78M -27298% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-22
Q1 2021 -$6.97M -$2.04M +$611K +23.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
Q4 2020 -$7.58M -$3.33M -$2.09M -168% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-15
Q3 2020 -$5.49M -$1.62M -$686K -73.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-22
Q2 2020 -$4.81M $13.8K +$1.17M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-20
Q1 2020 -$5.98M -$2.65M -$1.67M -171% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-24
Q4 2019 -$4.31M -$1.24M -$1.69M -376% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-15
Q3 2019 -$2.62M -$931K -$717K -335% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$1.9M -$1.16M -$1.01M -657% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$894K -$976K -$181K -22.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-29
Q4 2018 -$713K $450K +$2.89M Oct 1, 2018 Dec 31, 2018 10-K 2020-05-14
Q3 2018 -$3.6M -$214K +$3.33M +94% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-19
Q2 2018 -$6.92M -$153K +$3.74M +96.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-19
Q1 2018 -$10.7M -$795K +$3.18M +80% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$13.8M -$2.44M +$1.04M +29.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-10
Q3 2017 -$14.9M -$3.54M -$278K -8.52% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$14.6M -$3.9M -$226K -6.16% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$14.4M -$3.97M -$618K -18.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$13.8M -$3.48M +$503K +12.6% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-17
Q3 2016 -$14.3M -$3.26M +$337K +9.36% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$14.6M -$3.67M -$342K -10.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 -$14.3M -$3.35M -$575K -20.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 -$13.7M -$3.98M -$1.33M -50.4% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-30
Q3 2015 -$12.3M -$3.6M -$146K -4.23% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$12.2M -$3.33M +$596K +15.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-02
Q1 2015 -$12.8M -$2.78M -$149K -5.67% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 -$12.7M -$2.65M -$548K -26.1% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-25
Q3 2014 -$12.1M -$3.45M -$806K -30.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$11.3M -$3.92M -$2.27M -137% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 -$9.03M -$2.63M -$747K -39.7% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 -$8.28M -$2.1M -$426K -25.5% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-30
Q3 2013 -$7.85M -$2.65M -$408K -18.2% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 -$7.45M -$1.66M +$622K +27.3% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 -$8.07M -$1.88M +$4K +0.21% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 -$8.07M -$1.67M +$700K +29.5% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-30
Q3 2012 -$8.77M -$2.24M +$1.31M +37% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q2 2012 -$10.1M -$2.28M +$623K +21.5% Apr 1, 2012 Jun 30, 2012 10-Q/A 2013-10-18
Q1 2012 -$10.7M -$1.89M +$1.18M +38.6% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$11.9M -$2.37M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-20
Q3 2011 -$3.55M +$82K +2.26% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 -$2.9M +$2.13M +42.3% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-13
Q1 2011 -$3.07M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-11
Q3 2010 -$3.64M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-10
Q2 2010 -$5.03M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.